# Dosimetry of Tc-99m-Tilmanocept

> **NCT05241522** · PHASE1 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 57 (actual)

## Conditions studied

- Diabetic Kidney Disease

## Interventions

- **DIAGNOSTIC_TEST:** Tc-99m-Tilmanocept

## Key facts

- **NCT ID:** NCT05241522
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-06
- **Primary completion:** 2024-12-01
- **Final completion:** 2026-02-28
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05241522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05241522, "Dosimetry of Tc-99m-Tilmanocept". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05241522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*